<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib1170">
 <label>234</label>
 <element-citation publication-type="journal" id="sbref1170">
  <person-group person-group-type="author">
   <name>
    <surname>Zhu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Ye</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Su</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Improved pharmacological and structural properties of HIV fusion inhibitor AP3 over enfuvirtide: highlighting advantages of artificial peptide strategy</article-title>
  <source>Sci. Rep.</source>
  <volume>5</volume>
  <year>2015</year>
  <fpage>13028</fpage>
  <pub-id pub-id-type="pmid">26286358</pub-id>
 </element-citation>
</ref>
